ACM
Anfield Capital Management Portfolio holdings
AUM
$302M
This Quarter Return
+6.85%
1 Year Return
+14.39%
3 Year Return
+54.96%
5 Year Return
+95.56%
10 Year Return
–
AUM
$205M
AUM Growth
+$205M
(-2.4%)
Cap. Flow
-$21.9M
Cap. Flow
% of AUM
-10.69%
Top 10 Holdings %
Top 10 Hldgs %
57.35%
Holding
100
New
11
Increased
17
Reduced
52
Closed
15
Top Buys
Top Sells
| 1 |
DALT
Anfield Diversified Alternatives ETF
DALT
|
$8.32M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$7.23M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
$6.58M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
$5.62M |
| 5 |
Consumers Staples Select Sector SPDR Fund
XLP
|
$5.17M |
Sector Composition
| 1 | Real Estate | 1.84% |
| 2 | Financials | 1.45% |
| 3 | Healthcare | 1.14% |
| 4 | Energy | 0.41% |
| 5 | Utilities | 0.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Exelon
EXC
$44.1B
| $408K | 0.2% |
9,431
-929
| -9% | -$40.2K |
|
52
JPMorgan Ultra-Short Income ETF
JPST
$33.1B
| $407K | 0.2% |
8,083
-455
| -5% | -$22.9K |
|
53
Marathon Petroleum
MPC
$54.6B
| $406K | 0.2% |
3,488
-1,237
| -26% | -$144K |
|
54
McKesson
MCK
$85.4B
| $397K | 0.19% |
1,059
-294
| -22% | -$110K |
|
55
CenterPoint Energy
CNP
$24.6B
| $385K | 0.19% |
12,825
-2,712
| -17% | -$81.3K |
|
56
UnitedHealth
UNH
$281B
| $381K | 0.19% |
+719
| New | +$381K |
|
57
Enphase Energy
ENPH
$4.93B
| $341K | 0.17% |
+1,286
| New | +$341K |
|
58
Blackstone Secured Lending
BXSL
$6.88B
| $331K | 0.16% |
14,135
| – | – |
|
59
iShares Residential and Multisector Real Estate ETF
REZ
$809M
| $282K | 0.14% |
+3,882
| New | +$282K |
|
60
Apple
AAPL
$3.45T
| $277K | 0.14% |
1,961
-58
| -3% | -$8.18K |
|
61
The Mosaic Company
MOS
$10.6B
| $273K | 0.13% |
78,465
+70,053
| +833% | +$244K |
|
62
First Trust Value Line Dividend Fund
FVD
$9.18B
| $244K | 0.12% |
6,030
| – | – |
|
63
First Trust Rising Dividend Achievers ETF
RDVY
$16.4B
| $233K | 0.11% |
+5,000
| New | +$233K |
|
64
FS KKR Capital
FSK
$5.11B
| $222K | 0.11% |
11,501
| – | – |
|
65
Merck
MRK
$210B
| $178K | 0.09% |
1,605
-2,310
| -59% | -$256K |
|
66
AbbVie
ABBV
$372B
| $174K | 0.09% |
1,076
-879
| -45% | -$142K |
|
67
Regeneron Pharmaceuticals
REGN
$61.5B
| $165K | 0.08% |
228
-229
| -50% | -$165K |
|
68
Moderna
MRNA
$9.37B
| $163K | 0.08% |
910
-863
| -49% | -$155K |
|
69
Vertex Pharmaceuticals
VRTX
$100B
| $154K | 0.08% |
532
-711
| -57% | -$205K |
|
70
BioNTech
BNTX
$24B
| $151K | 0.07% |
1,004
-819
| -45% | -$123K |
|
71
Agilent Technologies
A
$35.7B
| $119K | 0.06% |
+797
| New | +$119K |
|
|
HZNP
72
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $80.2K | 0.04% |
705
-1,242
| -64% | -$141K |
|
73
Labcorp
LH
$23.1B
| $61.2K | 0.03% |
260
-602
| -70% | -$142K |
|
74
Incyte
INCY
$16.5B
| $59K | 0.03% |
734
-1,242
| -63% | -$99.8K |
|
75
Catalyst Pharmaceutical
CPRX
$2.52B
| $40.1K | 0.02% |
2,158
-1,920
| -47% | -$35.7K |
|